<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel rdf:about="http://schca-ir.schmc.ac.kr/handle/2022.oak/46">
    <title>Repository Collection:</title>
    <link>http://schca-ir.schmc.ac.kr/handle/2022.oak/46</link>
    <description />
    <items>
      <rdf:Seq>
        <rdf:li rdf:resource="http://schca-ir.schmc.ac.kr/handle/2022.oak/4722" />
        <rdf:li rdf:resource="http://schca-ir.schmc.ac.kr/handle/2022.oak/4686" />
        <rdf:li rdf:resource="http://schca-ir.schmc.ac.kr/handle/2022.oak/4685" />
        <rdf:li rdf:resource="http://schca-ir.schmc.ac.kr/handle/2022.oak/4548" />
      </rdf:Seq>
    </items>
    <dc:date>2026-10-23T07:06:49Z</dc:date>
  </channel>
  <item rdf:about="http://schca-ir.schmc.ac.kr/handle/2022.oak/4722">
    <title>A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo) adjuvant therapy in patients with early triple-negative breast cancer: Korean Cancer Study Group BR 15-1 PEARLY trial</title>
    <link>http://schca-ir.schmc.ac.kr/handle/2022.oak/4722</link>
    <description>Title: A randomized, multicenter, open-label, phase III trial comparing anthracyclines followed by taxane versus anthracyclines followed by taxane plus carboplatin as (neo) adjuvant therapy in patients with early triple-negative breast cancer: Korean Cancer Study Group BR 15-1 PEARLY trial
All Author(s): Joohyuk Sohn; Gun Min Kim; Kyung Hae Jung; Hei-Cheul Jeung; Jieun Lee; Keun Seok Lee; Seock-Ah Im; Seok Yun Kang; Se Hyun Kim; Han Jo Kim; Kyong Hwa Park; Yee Soo Chae; Su-Jin Koh; EUN KYUNG CHO; Keon Uk Park; Sung Sook Lee; Ji-Yeon Kim; In Sil Choi; Sun Kyung Baek; Yong Wha Moon</description>
    <dc:date>2023-12-31T15:00:00Z</dc:date>
  </item>
  <item rdf:about="http://schca-ir.schmc.ac.kr/handle/2022.oak/4686">
    <title>Nationwide real-world practice pattern and clinical data of palbociclib in patients with HR(+), HER2(-) metastatic breast cancer (KCSG BR21-15)</title>
    <link>http://schca-ir.schmc.ac.kr/handle/2022.oak/4686</link>
    <description>Title: Nationwide real-world practice pattern and clinical data of palbociclib in patients with HR(+), HER2(-) metastatic breast cancer (KCSG BR21-15)
All Author(s): Jieun Lee; Dae-Won Lee; Seock-Ah Im; Min Hwan Kim; Jee Hung Kim; Kyong Hwa Park; Jae Ho Byun; Kyoung Eun Lee; Myoung Joo Kang; Su-Jin Koh; Soojung Hong; Hye Sung Won; Han Jo Kim; In Hae Park; Seong Hoon Shin; Sun Kyung Baek; Seul-Gi Kim; Sung Ae Koh; Joo Young Jung; Yeon Hee Park</description>
    <dc:date>2023-12-31T15:00:00Z</dc:date>
  </item>
  <item rdf:about="http://schca-ir.schmc.ac.kr/handle/2022.oak/4685">
    <title>Hidden advertisements included in cancer information posts: Insights from social listening</title>
    <link>http://schca-ir.schmc.ac.kr/handle/2022.oak/4685</link>
    <description>Title: Hidden advertisements included in cancer information posts: Insights from social listening
All Author(s): Dalyong Kim; Joo Han Lim; Wonyoung Choi; Hyun Woo Lee; Ho Young Yoon; Kyung Han You; Sang-Cheol Lee</description>
    <dc:date>2023-12-31T15:00:00Z</dc:date>
  </item>
  <item rdf:about="http://schca-ir.schmc.ac.kr/handle/2022.oak/4548">
    <title>Comprehensive analysis of mutation and expression based pathways in head and neck squamous cell carcinoma</title>
    <link>http://schca-ir.schmc.ac.kr/handle/2022.oak/4548</link>
    <description>Title: Comprehensive analysis of mutation and expression based pathways in head and neck squamous cell carcinoma
All Author(s): B. Keam; I. S. Woo; H. J. Ahn; Y. G. Lee; S. H. Shin; S. C. Lee; H. Shim; K. E. Lee; M. Y. Choi; J. H. Lim; H. J. Kim; J. E. Hwang; S. Y. Oh; S. Park; H. Kim; B. C. Cho; H. J. Yun; J. Y. Park; G. D. Kim; Y. Yu</description>
    <dc:date>2017-12-31T15:00:00Z</dc:date>
  </item>
</rdf:RDF>

